What Are Viscosupplementation Injections?

Viscosupplementation injections deliver hyaluronic acid directly into a joint to restore the lubricating and cushioning properties of the natural fluid that arthritis gradually destroys. The procedure is used most commonly for knee osteoarthritis, though it has been explored in hips, shoulders, and ankles as well. Whether these injections actually outperform simpler alternatives is genuinely debated in orthopedic medicine, with major clinical guidelines disagreeing on whether to recommend them. That controversy, and what the evidence says beneath it, is worth understanding before you or your doctor decide whether viscosupplementation makes sense for your knee.

Why Joints Need Hyaluronic Acid in the First Place

Healthy joints contain synovial fluid, a slippery liquid that serves two roles at once: it lubricates the surfaces where bones meet, and it absorbs shock during movement. Hyaluronic acid is the molecule that gives synovial fluid those properties. When the hyaluronic acid is intact and present at normal concentrations, the fluid behaves almost like a gel under sudden impact but flows freely during slow movement.¹

In osteoarthritis, the hyaluronic acid in synovial fluid breaks down. Its concentration drops and its molecular chains shorten, meaning the fluid loses both its lubricating ability and its capacity to cushion the joint against impact.² Cartilage surfaces that were once gliding smoothly against each other start grinding, wearing down faster, and triggering inflammation. Viscosupplementation is an attempt to put back what arthritis has taken away.

How the Injections Work Beyond Simple Lubrication

The original idea behind viscosupplementation was purely mechanical: inject a thick gel into the joint, restore the fluid’s consistency, and let the knee move more smoothly. That mechanical restoration does happen. Hyaluronic acid injections improve the viscoelasticity of the joint fluid, which means better lubrication and better shock absorption during walking, climbing stairs, and other weight-bearing activity.³

But the injected hyaluronic acid does not just sit in the joint acting as a lubricant. Research has shown it triggers several biological effects: it stimulates the production of proteins that support the cartilage matrix, it dials down inflammatory molecules involved in joint destruction, it limits the movement of immune cells that drive inflammation, and it helps preserve cartilage thickness and surface smoothness.⁴ A pilot study tracking inflammatory markers in synovial fluid found that patients experienced roughly a 50% reduction in pain over six months, and that the degree of pain reduction correlated with decreases in specific inflammatory molecules in the joint.⁵ These anti-inflammatory and protective effects are part of the reason benefits can persist for months, well after the injected hyaluronic acid itself has been cleared from the joint.

Does It Actually Work? What the Evidence Shows

This is where the picture gets interesting, because the answer genuinely depends on whom you ask and what standard you use. A large umbrella review that compiled the findings of 22 separate systematic reviews and meta-analyses found that the vast majority reported statistically significant improvements in pain and function from hyaluronic acid injections compared with placebo. But the authors of those reviews did not always agree on whether the improvements were large enough to matter clinically. Of the five highest-quality reviews in the set, all five found significant benefits, yet three interpreted the results positively and two concluded negatively.⁶

This split is not about whether hyaluronic acid injections reduce pain compared with baseline. They clearly do. The debate is about whether the improvement over a saline placebo injection is large enough to be clinically meaningful, since placebo injections into the knee also produce a surprisingly robust response. Some researchers set a high bar for what counts as a meaningful improvement and find viscosupplementation falls just short. Others set a lower bar, or focus on the duration of relief rather than the peak magnitude, and conclude it works.

That ambiguity has spilled over into clinical guidelines, which are notably inconsistent. A systematic review of practice guidelines from around the world found that recommendations for hyaluronic acid injections in knee osteoarthritis varied widely among higher-quality guidelines, with some endorsing the treatment and others advising against it.⁷ The American Academy of Orthopaedic Surgeons, for instance, has historically been skeptical, while other professional societies have been more supportive. If your doctor and your friend’s doctor give you different advice, this is why.

How They Compare to Corticosteroid Injections

Corticosteroid injections are the other major category of knee injection for osteoarthritis, and they work quite differently. Steroids are powerful anti-inflammatory drugs that shut down pain quickly but wear off relatively fast. Hyaluronic acid, by contrast, is slower to kick in but tends to last longer. The research backs this up in a consistent pattern across multiple meta-analyses.

In the first month after injection, corticosteroids outperform hyaluronic acid for pain relief. By about four weeks, the two are roughly equal. Beyond eight weeks, hyaluronic acid pulls ahead and maintains its advantage out to about six months.⁸ A separate meta-analysis confirmed this trajectory, finding corticosteroids were better at one month but hyaluronic acid showed greater pain reduction and better function scores at six months.⁹

This timeline matters for practical decisions. If you need rapid relief for a flare-up, or you are trying to get through a specific event, a corticosteroid shot may be more appropriate. If you are looking for longer-lasting symptom management and are willing to wait a few weeks for the effect to build, hyaluronic acid may be the better option. Some clinicians now combine the two, which is discussed later in this article.

Platelet-Rich Plasma as an Alternative

Platelet-rich plasma, or PRP, has emerged as a newer competitor to viscosupplementation. PRP is made from your own blood: a sample is drawn, spun down to concentrate the platelets and growth factors, and then injected into the joint. Two meta-analyses comparing PRP to hyaluronic acid in knee osteoarthritis have found PRP to be more effective for pain and function at follow-ups of six and twelve months.¹⁰ One of these reported that mean improvement was significantly higher in the PRP group for overall joint function scores.¹¹

There is a catch, though. PRP is not covered by most insurance plans, which makes it significantly more expensive out of pocket. There is also no standardized preparation protocol for PRP, which means the concentration and composition of what gets injected can vary dramatically from clinic to clinic. Hyaluronic acid products, by contrast, are manufactured to consistent specifications. The adverse event rates between PRP and hyaluronic acid appear to be similar, so safety is not the deciding factor. Cost, insurance coverage, and how much you trust your clinic’s PRP preparation are the real considerations.

Who Responds Best

Not everyone benefits equally from viscosupplementation, and a few predictors stand out. Patients with milder arthritis (grades 1 to 2 on the standard radiographic scale) are at least twice as likely to respond well compared with those who have more advanced disease. Being 60 or older and having a positive response to the first injection are also strong predictors of overall success.¹²

This means viscosupplementation tends to work best as an earlier intervention, not as a last resort before surgery. If you have bone-on-bone arthritis with severe narrowing of the joint space, the injections are less likely to provide meaningful relief. They are better suited for the phase when cartilage is thinning but still present, when the joint’s internal environment can still be meaningfully improved by restoring its fluid properties.

The Injection Itself

Viscosupplementation is an office procedure. The knee is cleaned, and the injection is given with a standard needle into the joint space. Some physicians inject without imaging guidance, relying on anatomical landmarks to find the right spot. Others use ultrasound to guide the needle in real time. The evidence strongly favors the ultrasound approach: a systematic review of randomized trials found that ultrasound-guided knee injections were more accurate than blind injections in every study examined.¹³ Another review estimated that ultrasound guidance achieved accuracy rates near 96%, compared with about 78% for landmark-based injections.¹⁴

Accuracy matters because if the hyaluronic acid ends up in the soft tissue surrounding the joint rather than inside it, the treatment will not work as intended. If your provider offers ultrasound guidance, it is worth accepting. The procedure itself takes only a few minutes, and most people return to normal activity within a day or two.

How Many Injections and How Often

Hyaluronic acid products come in different regimens. Some are designed as a single injection, others as a series of three weekly shots, and a few require five weekly sessions. A systematic review comparing these dosing schedules found no consistent difference in patient outcomes between single-injection and multiple-injection formulations, and five-injection products did not appear to outperform three-injection products.¹⁵ This is good news practically, because it means fewer office visits may get you the same result.

As for repeat courses, the evidence suggests they are both safe and effective. A systematic review of repeated treatment cycles found that pain relief was sustained or improved with each subsequent course. The longest-followed study in that review administered injections every six months for over two years and found that pain continued to decrease after each round, reaching roughly 55% reduction from baseline by the end.¹⁶ Most clinicians recommend repeating treatment every six to twelve months when the initial course is effective.

Safety and Side Effects

Viscosupplementation has a strong safety record. The most common side effects are mild and transient: temporary pain at the injection site, some swelling, and occasional stiffness for a day or two. Serious adverse events are rare. A large analysis based on hundreds of thousands of injections found that the rate of inflammation or infection within three days of an injection was only about 0.02%, regardless of which type of hyaluronic acid product was used.¹⁷

There has been some historical concern that certain product types, particularly those derived from rooster combs (avian-derived) or those that are chemically cross-linked for longer residence in the joint, might carry a higher risk of flare reactions. The evidence is mixed. One study found that fermentation-derived products had fewer injection-site flare-ups than avian-derived ones.¹⁸ But a separate real-world analysis of nearly 700,000 injections found no clear correlation between avian derivation or cross-linking and severe local reactions, with rates varying more by specific brand than by broad product category.¹⁹ Overall, the risk profile is low regardless of product type.

Combining Hyaluronic Acid with Corticosteroids

Because corticosteroids and hyaluronic acid have complementary timelines, the idea of combining them in one injection has obvious appeal: get the fast pain relief from the steroid and the longer-lasting benefits from the hyaluronic acid. The research supports this approach in the short term. A randomized trial found that co-injection of hyaluronic acid and a corticosteroid provided faster pain relief and better knee function at one week, one month, and three months compared with hyaluronic acid alone, though the long-term outcomes evened out.²⁰

A separate trial looking at repeated co-injections over time found more sustained advantages, with the combination group showing better pain scores and physical function than the hyaluronic acid-only group across multiple follow-ups.²¹ This combination strategy is not yet standard practice everywhere, but it is gaining traction, particularly for patients who have had a good response to hyaluronic acid but want quicker onset.

Can Viscosupplementation Delay Knee Replacement?

One of the more compelling arguments for viscosupplementation, particularly in the debate over guideline recommendations, comes from large observational studies on joint replacement timing. An analysis of a major U.S. health claims database found that patients who received hyaluronic acid injections had a longer delay before undergoing knee replacement compared with those who did not. The relationship was dose-dependent: patients who received no hyaluronic acid went to surgery at a mean of about 0.7 years, those who received one course delayed surgery to an average of 1.4 years, and those who received five or more courses delayed surgery by an average of 3.6 years.²² A Korean claims-database study found the same pattern, with knee replacement risk decreasing as the number of injection cycles increased.²³

These are observational findings, which means they cannot definitively prove that the injections caused the delay rather than reflecting patient self-selection or other factors. But the consistency of the dose-response pattern across different databases and countries is suggestive. For patients who are not yet ready for surgery, or who want to put it off as long as possible, this data point matters. It also feeds into the cost-effectiveness argument, since knee replacement is a far more expensive intervention than a series of injections. An economic analysis found that compared with conventional care, all investigated hyaluronic acid products were cost-effective under standard willingness-to-pay thresholds.²⁴

Beyond the Knee

Most of the research on viscosupplementation focuses on the knee, and that is where the strongest evidence base exists. When researchers have looked at other joints, the picture is less clear. A systematic review covering osteoarthritis of the hip, ankle, shoulder, and other non-knee joints found statistical evidence that patients improved after hyaluronic acid injections, but limited evidence that the improvement was better than what a placebo would have produced, and no evidence that it outperformed corticosteroids or other conservative treatments for those joints.²⁵

A meta-analysis focused specifically on the shoulder found that while patients experienced meaningful pain improvement at three and six months after injection, the improvements were similar to those seen in control groups, suggesting the benefit might come from the injection procedure itself rather than from hyaluronic acid specifically.²⁶ A Canadian health technology assessment looking at hip, shoulder, and ankle found that the available studies were too small and too poorly designed to draw confident conclusions, though serious side effects were not reported.²⁷ If your doctor suggests viscosupplementation for a non-knee joint, the honest answer is that the evidence is thinner and less convincing than it is for the knee.

Early Signs of a Disease-Modifying Effect

Most arthritis treatments manage symptoms without changing the underlying progression of the disease. Cartilage continues to wear away whether or not you feel less pain. The question of whether hyaluronic acid injections might actually slow cartilage loss has produced some intriguing early results, though the evidence is far from settled.

A two-year clinical trial used MRI to track cartilage volume in patients who received injections every six months compared with a control group. The treatment group lost significantly less cartilage in both the inner and outer compartments of the knee, and showed fewer cartilage defects on imaging.²⁸ Another study found that patients who received hyaluronic acid injections after a surgical procedure for knee realignment showed increased cartilage volume compared with a control group.²⁹

These findings are preliminary. The studies were small, and structural changes on imaging do not always translate to better long-term clinical outcomes. But the possibility that hyaluronic acid could act as a disease-modifying agent, not just a symptom manager, is one of the more active areas of osteoarthritis research. If larger trials confirm these results, it could shift the entire conversation about when and why to start viscosupplementation, potentially pushing it earlier in the disease course rather than treating it as a late-stage option.